Lead Sponsor

Daewoong Pharmaceutical Co. LTD.

Age

19 - 80 years

Sex

ALL

Healthy Volunteers

No

•2. Voluntarily decided to participate in the extension study and provided a written consent on the consent form

•1. Those who dropped out of the previously conducted phase 3 clinical trial (Protocol No: DW\_DWP16001301)
•2. Pregnant or lactating women or those who do not consent to the use of appropriate contraceptive methods during clinical trials Appropriate method of birth control for you or your partner: You must agree to one of the following
•* Either surgical sterilization (vasectomy, etc.) or insertion of an intrauterine device (copper loop, intrauterine hormone-containing system), or
•* A physical barrier method combined with either systemic hormonal contraceptives or spermicide, or
•* Use of male condom combined with either cervical cap or diaphragm
•3. In case the investigator judges that participation in this extended clinical trial is inappropriate in consideration of the 24-week observation progress in the previously conducted phase 3 clinical trial (Protocol No: DW\_DWP16001301)